Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.
about
Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesA Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseSynthetic pharmacotherapy for lupus nephritis.Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation.Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant.Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.Genetics of acute rejection after kidney transplantation.CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study.Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation.CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment.
P2860
Q33838866-B2485E25-92CB-417A-8CE0-999AC79BB029Q38691788-DE2FBBCF-651B-4B94-AE65-E10C420FD06FQ38865683-69E1ED7B-90F0-470B-9713-3CCE54233A5AQ39064602-38A4B33C-0CFC-4213-885A-62031F0B00D2Q42215557-D6EB2548-4D8F-4A1B-A2A2-4806E33EB45AQ46357849-81DB5C68-C5FF-42A8-962C-96EFA08677B4Q47242677-FA163257-D2F6-44E5-BB90-340EBF066647Q47741403-F650280C-E339-4764-8385-BE66C380AD29Q47898148-ED7F44DD-0E59-4B79-83D9-0940366E5FF7Q48172244-C10875A4-6247-4B64-99B6-2DEA5F3B468FQ52859440-BD288FD7-F845-4FE8-8AB8-555C4B946DA9Q55002551-83D59B33-6BF8-4E17-99D0-2FB0B7B2F5B5Q55280859-34DCC898-A05C-4AEE-B823-09AC027B1D83
P2860
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacogenetic aspects of the ...... nts and ethnic considerations.
@en
type
label
Pharmacogenetic aspects of the ...... nts and ethnic considerations.
@en
prefLabel
Pharmacogenetic aspects of the ...... nts and ethnic considerations.
@en
P2093
P2860
P1476
Pharmacogenetic aspects of the ...... nts and ethnic considerations.
@en
P2093
D A Hesselink
L M Andrews
R H N van Schaik
T van Gelder
P2860
P304
P356
10.1517/17425255.2016.1170808
P407
P577
2016-03-24T00:00:00Z